Published in HPB (Oxford) on March 01, 2010
Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases. Ann Surg Treat Res (2014) 0.82
Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy? Korean J Hepatobiliary Pancreat Surg (2011) 0.79
Critical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastases. HPB (Oxford) (2014) 0.77
Extended pathology reporting of resection specimens of colorectal liver metastases: the significance of a tumour pseudocapsule. HPB (Oxford) (2012) 0.76
Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin. Medicine (Baltimore) (2016) 0.76
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.75
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med (2000) 18.12
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet (2000) 12.56
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol (2005) 4.92
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol (2004) 4.78
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg (1990) 4.36
One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg (2003) 3.84
Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet (1968) 3.33
Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg (2005) 3.29
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg (2003) 3.14
Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg (1992) 2.97
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg (2004) 2.65
Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 2.62
Determinants of survival in liver resection for colorectal secondaries. Br J Surg (1986) 2.58
A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg (1987) 2.54
Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol (2007) 2.42
Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35
Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg (2007) 2.35
The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg (2007) 2.23
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22
Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie. Br J Surg (1997) 2.18
Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol (2006) 2.02
A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res (2006) 2.02
Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg (2007) 1.85
An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer (2006) 1.75
The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer (2005) 1.69
Repeat hepatectomy for colorectal liver metastases: A worthwhile operation? J Surg Oncol (2001) 1.63
Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood (1999) 1.48
One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg (2003) 1.35
Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis. World J Surg (2004) 1.27
C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer (2007) 1.21
Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 1.15
Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery (2001) 1.12
Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol (2007) 1.12
Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet (2005) 1.10
Outcomes after major hepatectomy in elderly patients. J Am Coll Surg (2006) 1.03
A review of techniques for liver resection. Ann R Coll Surg Engl (2002) 1.00
Prolongation effect of blood transfusions on kidney graft survival. Transplantation (1976) 0.95
Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis. Jpn J Clin Oncol (2006) 0.92
Repeat hepatectomy for recurrent hepatic metastases from colorectal cancer. Hepatogastroenterology (2001) 0.90
Outcome following repeat liver resection for colorectal liver metastases. Eur J Surg Oncol (2007) 0.88
Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int (2011) 2.85
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
The prognostic value of the neutrophil-lymphocyte ratio (NLR) in acute pancreatitis: identification of an optimal NLR. J Gastrointest Surg (2013) 1.70
Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol (2008) 1.64
Right hepatic trisectionectomy for hepatobiliary diseases: results and an appraisal of its current role. Ann Surg (2007) 1.62
Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations. Liver Transpl (2011) 1.52
Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg (2004) 1.49
Internal jugular vein thrombosis in a warfarinised patient: a case report. J Med Case Rep (2007) 1.46
Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg (2010) 1.45
The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound (2003) 1.43
A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resection. Ann R Coll Surg Engl (2009) 1.42
Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg (2007) 1.35
Emergency presentation of abdominal hernias: outcome and reasons for delay in treatment - a prospective study. Ann R Coll Surg Engl (2007) 1.34
Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg (2008) 1.30
Surgical strategy for cystic diseases of the liver in a western hepatobiliary center. World J Surg (2002) 1.28
Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. J Gastrointest Surg (2012) 1.17
Laparoscopic vs open pancreaticoduodenectomy. J Am Coll Surg (2013) 1.15
Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology (2005) 1.09
Inferior vena cava resection with hepatectomy: challenging but justified. HPB (Oxford) (2011) 1.06
Hemoperitoneum secondary to rupture of cystic artery pseudoaneurysm. Hepatobiliary Pancreat Dis Int (2007) 1.04
Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation (2009) 1.04
New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res (2007) 1.03
Sclerosing Angiomatoid Nodular Transformation (SANT) of the spleen: Case report and review of the literature. Int J Surg Case Rep (2012) 1.02
Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann Surg (2005) 1.01
Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol (2008) 0.99
Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Sci (2009) 0.99
Bile duct strictures after hepatobiliary surgery: assessment with MR cholangiography. Radiology (2004) 0.98
Treatment and surveillance of polypoid lesions of the gallbladder in the United Kingdom. HPB (Oxford) (2012) 0.97
Adenoid cystic carcinoma of the base of the tongue: Late metastasis to the pancreas. Int J Surg Case Rep (2010) 0.94
The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology (2003) 0.94
Indication for treatment and long-term outcome of focal nodular hyperplasia. HPB (Oxford) (2007) 0.94
Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl (2013) 0.93
Results of pancreatic surgery in the elderly: is age a barrier? HPB (Oxford) (2012) 0.93
Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. J Am Coll Surg (2011) 0.91
Pre-operative prediction of pancreatic fistula: is it possible? Pancreatology (2013) 0.91
Portal vein arterialization as a salvage procedure during left hepatic trisectionectomy for hilar cholangiocarcinoma. J Am Coll Surg (2008) 0.90
Fibroblast growth factor 21 as a biomarker for NAFLD: integrating pathobiology into clinical practice. J Hepatol (2010) 0.90
Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg (2007) 0.89
Techniques of radiofrequency-assisted precoagulation in laparoscopic liver resection. Surg Endosc (2010) 0.89
Kinetics of liver function tests after a hepatectomy for colorectal liver metastases predict post-operative liver failure as defined by the International Study Group for Liver Surgery. HPB (Oxford) (2012) 0.88
Predictors of blood transfusion requirement in elective liver resection. HPB (Oxford) (2010) 0.88
Metabonomics: a useful tool for the future surgeon. J Surg Res (2009) 0.88
Transcriptional profile of genes involved in oxidative stress and antioxidant defense in a dietary murine model of steatohepatitis. Antioxid Redox Signal (2011) 0.88
Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review. Hepatobiliary Pancreat Dis Int (2014) 0.87
Pancreaticopleural fistula: etiology, treatment and long-term follow-up. Hepatobiliary Pancreat Dis Int (2012) 0.87
Acceptable outcome after kidney transplantation using "expanded criteria donor" grafts. Transplantation (2010) 0.87
One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach. Ann Surg (2014) 0.87
Pancreatico-psoas fistula: a rare complication of acute pancreatitis. BMJ Case Rep (2012) 0.86
Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxford) (2011) 0.86
Is a bougie required for the performance of the fundal wrap during laparoscopic Nissen fundoplication? Surg Endosc (2009) 0.85
Identification and use of the putative Bacteroides ovatus xylanase promoter for the inducible production of recombinant human proteins. Microbiology (2008) 0.84
Repeat liver resection after a hepatic or extended hepatic trisectionectomy for colorectal liver metastasis. HPB (Oxford) (2013) 0.84
Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation. Transpl Int (2012) 0.84
Subtotal hepatectomy and whole graft auxiliary transplantation for acetaminophen-associated acute liver failure. HPB (Oxford) (2013) 0.84
Ischemia- reperfusion injury and its influence on the epigenetic modification of the donor kidney genome. Transplantation (2008) 0.84
A combined liver-pancreas en-bloc transplant in a patient with cystic fibrosis. Transplantation (2005) 0.84
Preoperative vascular imaging in pediatric liver transplantation. J Pediatr Surg (2005) 0.84
Rate of growth of pancreatic serous cystadenoma as an indication for resection. Surgery (2013) 0.84
A cost effective analysis of a laparoscopic versus an open left lateral sectionectomy in a liver transplant unit. HPB (Oxford) (2014) 0.83
Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1. Inflamm Bowel Dis (2010) 0.83
Laparoscopic left lateral sectionectomy: surgical technique and our results from Leeds. J Laparoendosc Adv Surg Tech A (2009) 0.83
Operative terminology and post-operative management approaches applied to hepatic surgery: Trainee perspectives. World J Gastrointest Surg (2013) 0.83
Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot study. HPB (Oxford) (2012) 0.82
Hepatic resection for colorectal metastasis: impact of tumour size. Ann Surg Oncol (2006) 0.82
Multicenter, randomized study of the effectiveness of basiliximab in avoiding addition of steroids to cyclosporine a monotherapy in renal transplant recipients. Transplantation (2005) 0.82
Single-incision laparoscopic cholecystectomy: do patients care? J Gastrointest Surg (2011) 0.81
Colonic diaphragm disease without significant non-steroidal anti-inflammatory drug use: a case report. Cases J (2008) 0.81
Current techniques and results of liver resection for colorectal liver metastases. Br Med Bull (2004) 0.81
Duodenal perforation secondary to migration of endobiliary prosthesis. BMJ Case Rep (2012) 0.81
Contemporary management and classification of hepatic leiomyosarcoma. HPB (Oxford) (2014) 0.80
Vascular surgery, ICU and HDU: a 14-year observational study. Ann R Coll Surg Engl (2008) 0.80
A pathophysiologic study of the kidney tubule to optimize organ preservation solutions. Kidney Int (2004) 0.80
Bleeding stomal varices: a marker of chronic liver disease. BMJ Case Rep (2009) 0.79
Has free radical release across the brain after carotid endarterectomy traditionally been underestimated? Significance of reperfusion hemodynamics. Stroke (2007) 0.79
A unique cause of intestinal and splenic infarction in a sickle cell trait patient. Case Rep Surg (2013) 0.79
Minimally invasive surgery training using multiple port sites to improve performance. Surg Endosc (2014) 0.79
Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation? HPB (Oxford) (2012) 0.79
Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantation. Transplantation (2008) 0.78
An imperative need to change organ donation and transplant curriculum results of a nationwide United kingdom junior doctor survey. Transplantation (2015) 0.78
Epidural versus local anaesthetic infiltration via wound catheters in open liver resection: a meta-analysis. ANZ J Surg (2014) 0.78
The White test: a real benefit? Arch Surg (2009) 0.78
Results following surgical resection for malignant pancreatic neuroendocrine tumours. A single institutional experience. JOP (2008) 0.78
Kidney transplantation using the inferior epigastric vessels for multiple anastomoses from a pelvic kidney. J Am Coll Surg (2009) 0.78
The Modified Early Warning Score (MEWS): an instant physiological prognostic indicator of poor outcome in acute pancreatitis. JOP (2014) 0.77
A modern approach to teaching pancreatic surgery: stepwise pancreatoduodenectomy for trainees. J Gastrointest Surg (2012) 0.77
An in vitro model of warm hypoxia-reoxygenation injury in human liver endothelial cells. J Surg Res (2012) 0.76
Prognostic value of the lymph node ratio after resection of periampullary carcinomas. HPB (Oxford) (2012) 0.76
Lymphoepithelial cysts of the pancreas:a management dilemma. Hepatobiliary Pancreat Dis Int (2014) 0.76
The diagnostic dilemma of Parkinson's disease as a cause of calf 'claudication'. Br J Gen Pract (2005) 0.75
Enterocutaneous fistula 3 years after resection of an advanced gallbladder carcinoma. BMJ Case Rep (2014) 0.75